The Global Surgical Drains Market is estimated to be valued at USD 2.87 Bn in 2025 and is expected to reach USD 4.49 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. This growth is driven by the rising number of surgical procedures worldwide, increasing demand for minimally invasive surgeries, and advancements in surgical drain technologies, which collectively enhance patient recovery and reduce complications.
The market trend indicates a significant shift towards the adoption of advanced, biocompatible, and smart surgical drains that offer better fluid management and infection control. Additionally, growing awareness among healthcare professionals and patients about post-surgical care and the integration of digital monitoring systems in surgical drains are fueling the market expansion. Furthermore, emerging economies are witnessing increased healthcare investments, which is further supporting the demand for surgical drains in both hospital and outpatient settings.
|
Current Events |
Description and its Impact |
|
Accelerated Adoption of Advanced Surgical Drains |
|
|
Surge in Complex Surgeries Worldwide |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Closed drainage systems are expected to hold the largest share of 54.2% in 2025. These drains prevent infection and offer the best fluid management during the postoperative phase.
In contrast to open drainage systems, closed systems eliminate any external contaminant that may get into the wound site, which is very vital in minimizing the occurrence of postoperative complications like surgical site infections (SSIs).
The reason passive drains retain the leading position in the surgical drains market, with an estimated share of 65.1% in 2025, is their simple mechanism of action. They use natural pressure differentials and gravity to evacuate surgical sites of fluids. Such drains are not necessarily connected to external suction machines and this makes them simpler to use between the surgeons and the nursing staff in perioperative care units.
Passive drainage systems are highly used because of the reliability of the system. They are simply designed in tubular or flat form, enabling fluid to pass spontaneously which reduces mechanical failures and facilitates easy maintenance.
The most successful application segment in the surgical drains market is general surgery, with an estimated share of 23.4% in 2025. This success is due to the wide range of both routine and multifaceted surgical procedures that require efficient management of wound drainage. Hernia repairs, appendectomies, cholecystectomies, and gastrointestinal surgeries fall under this specialty in which all of these procedures tend to cause fluid retention at the surgical site which requires the use of drains.
In June 2025, PolyPid, a biopharmaceutical company focused on localized drug delivery solutions, reported positive Phase 3 results for its D-PLEX100 therapy, showing strong effectiveness in preventing surgical site infections following abdominal colorectal surgery.
|
Country/Region |
Regulatory Authority |
Approval Pathway |
Device Classification |
Key Regulatory Focus Areas |
Example (Device) |
|
U.S. |
U.S. Food and Drug Administration (FDA) |
510(k) Premarket Notification: Required for moderate-risk (Class II) devices proving substantial equivalence to an existing product. Premarket Approval (PMA): Required for high-risk or novel smart-enabled surgical drain systems. |
Class II – General & Plastic Surgery Devices (21 CFR 878.4200) |
Biocompatibility and sterility testing. Mechanical safety and drain performance. Demonstration of substantial equivalence. |
Jackson-Pratt Hemaduct Wound Drain Allegiance Healthcare Corp. (510(k) No. K973703) |
|
European Union |
European Medicines Agency (EMA) and Notified Bodies under Medical Device Regulation (MDR 2017/745) |
CE Mark Certification: Issued after conformity assessment confirming compliance with MDR safety, performance, and risk standards. |
Class IIa or IIb Medical Device (depending on duration and invasiveness) |
• Clinical safety and performance validation. • Risk management and biocompatibility assessment. • Post-Market Clinical Follow-up (PMCF) |
Blake Drainage |
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
|
Country/Region |
Reimbursement Authority |
Reimbursement System |
Impact on Hospital Purchasing Decisions |
|
U.S. |
Centers for Medicare & Medicaid Services (CMS) |
Reimbursement through Healthcare Common Procedure Coding System (HCPCS) and Diagnosis-Related Group (DRG) codes. Promotes Value-Based Purchasing (VBP) models. |
Hospitals prioritize outcome-driven, cost-efficient drains that reduce infection risk and hospital stay. Demand rising for pre-assembled drain kits and smart suction systems. |
|
Japan |
Ministry of Health, Labour and Welfare (MHLW) |
Technical Fee-Based Reimbursement System with predefined device cost limits. Uses National Health Insurance (NHI) pricing for approved medical devices. |
Hospitals select devices showing clinical efficacy and economic value. Preference for domestically produced, reusable, or biodegradable drains to meet budget and sustainability targets. |
|
European Union |
National Health Authorities/Public Payers |
Reimbursement via DRG-based or Bundled Care Payment systems. Supports Value-Based Healthcare (VBHC) frameworks. |
Hospitals favor CE-certified drains with proven clinical benefits and cost savings. Procurement decisions driven by infection control, faster recovery, and total treatment cost reduction. |
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Download Free Sample
North America is expected to dominate the global surgical drains market, holding the largest share of 40.3% in 2025. This is due to its strong healthcare spending, positive reimbursement policy, and extensive use of minimally invasive and post-operative care methods which extensively use surgical drain solutions. The availability of large medical equipment companies drives competitive product development through improvement in product offerings in terms of innovative designs of drains and bio-compatible materials.
For example, in September 2024, Baxter International Inc., a global medtech company, launched The Vest APX System for patients with chronic lung conditions, enhancing comfort and airway clearance efficiency. The company also continues advancing its surgical drains portfolio to improve post-operative fluid management and infection control.
Asia Pacific is expected to experience the fastest growth in the global surgical drains market, with a share of 25.3% in 2025. This growth is driven by a rising patient base, increasing healthcare awareness, and a higher number of surgical procedures in emerging economies like China, India, Japan, and South Korea.
Governments in these countries, including China, India, and Japan, are focusing on developing healthcare infrastructure and improving accessibility. They are also promoting domestic production through policies and incentives aimed at fostering the growth of the local industry.
The U.S. is still a key market given its developed healthcare delivery system and current use of the newest technologies in surgical procedures. The key players, including Medtronic, Ethicon (Johnson & Johnson), and 3M, are focused on research and development to create advanced surgical drainage systems that reduce the risk of infection and promote faster recovery.
In December 2024, U.S.-based, ViaLase Inc. partnered with the John A. Moran Eye Center to advance glaucoma research using its ViaLuxe laser and iPerfusion technology. The company’s focus on fluid drainage aligns with growing advancements in surgical drains improving post-operative recovery and infection control.
Germany is one of the industry leaders in the Europe surgical drains market, which has a developed healthcare sector and focuses on the development of medical devices. The presence of companies such as B. Braun Melsunge and Karl Storz is large, and they have brought innovative solutions that could suit different surgical requirements.
In June 2024, B. Braun Interventional Systems, a global medical technology company, introduced its ACCEL All-Purpose and Biliary Drainage Catheters, featuring TrueGlide Hydrophilic Coating to improve catheter performance and ease of use in drainage procedures.
China is a dynamic and quickly developing market because of the activities of the government, which is intended to develop healthcare facilities and make access to surgical care more accessible in both urban and rural areas. The presence of domestic companies as well as multinational companies such as Stryker and Medtronic are increasing their competition by forming strategic partnerships and local manufacturing units to ensure that the increasing demand is fulfilled at a reasonable price.
In August 2023, Brain Navi, a China-based medical robotics firm, showcased its NaoTrac neurosurgical robot and KrystoLens neuro-endoscope at global conferences, highlighting precision in brain procedures like external ventricular drainage. The progress aligns with advancements in surgical drains improving post-surgery recovery and infection control.
The surgical drains market in India is growing due to the increasing number of surgical cases due to population shift, growing number of chronic diseases that need surgery, and government impetus on enhancing healthcare accessibility through initiatives such as Ayushman Bharat.
Key players in India’s surgical drains market include Poly Medicure Ltd, Hindustan Syringes & Medical Devices Ltd, Global Medikit Ltd, and Angiplast Pvt. Ltd, all offering cost-effective drainage systems for hospitals. Global firms such as Medtronic plc and Teleflex Incorporated are also expanding locally with advanced vacuum-assisted surgical drain solutions.

To learn more about this report, Download Free Sample
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.87 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.6% | 2032 Value Projection: | USD 4.49 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
B. Braun Melsungen AG, Cardinal Health, Inc., Cook Medical (Cook Group), Medtronic plc, Teleflex Incorporated, Stryker Corporation, Johnson and Johnson (Ethicon), Smith and Nephew plc, Becton Dickinson (C. R. Bard), Acelity, ConvaTec Group plc, Romsons Group, Redax S.p.A, Poly Medicure Ltd, and Global Medikit Limited |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Download Free Sample
The growing number of surgical operations carried out in the world is also a strong force that is fueling the market for surgical drains. With the increasing quality of healthcare facilities and availability of modern medical services, the number of patients seeking surgical procedures in different specialties increases in orthopedics, general surgery, cardiovascular, and oncology, among others. This explosion of surgical cases can be directly associated with an increase in demand for effective post-operative care interventions, such as the application of surgical drains to address the issue of fluid build-up, infection prevention, and wound recovery.
In January 2024, Truist Securities, the investment research division of Truist Financial Corporation, released a quarterly hospital survey, highlighting a steady rise in U.S. surgical procedure volumes. The firm’s analysts found that procedures grew 2–3% over the previous quarter, with interventional cardiology leading the increase. Medtronic, Boston Scientific, and Edwards Lifesciences are expected to benefit from higher cardiology volumes, while Intuitive Surgical may gain from stronger bariatric surgery demand and a 3.5% rise in hospital capital spending.
There is a revolutionary opportunity being experienced in the global surgical drains market through the introduction of antimicrobial and smart surgical drains with advanced sensor technology. Although traditional surgical drains are effective in fluid removal and preventing complications after surgery, they have limitations, including the risk of infection, inefficient monitoring of drain patency, and inaccurate drain output assessment. The development of antimicrobial-coated or antimicrobial-material surgical drains is crucial, as it minimizes the risk of infection at the surgical site, which can otherwise lead to prolonged hospital stays and higher medical expenses
In September 2025, FluidAI Medical, a Canadian healthtech firm, gained the USFDA 510(k) clearance for its Origin device, which enables real-time monitoring of surgical drains. The system tracks biochemical data like pH at the bedside, supporting faster recovery and fewer readmissions through AI-assisted clinical insights.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients